Search

everythinglearnresearchcommunity

for

Search:↓

The treatment improved acne, seborrhoea, and hirsutism, with some side effects like spotting and nervousness.

Treatment with a hormone agonist can reduce excess male hormones in postmenopausal women without surgery.

Aromatase inhibitors can cause various adverse reactions, so monitoring is crucial.

Cyproterone acetate-estrogen most effective for hirsutism, but consider side effects and patient needs.

Testosterone therapy can help postmenopausal women with low sexual desire but needs more safety research and should be used with estrogen therapy.

Cyproterone acetate is a safe treatment that causes mild feminizing effects and is more effective with added estrogens.

Effective treatments for excessive body hair in women include drugs that block androgens, sometimes combined with oral contraceptives.

Cyproterone acetate effectively treats virilized women, especially under 35, despite some side effects.

The treatment temporarily improved symptoms of hyperandrogenism in adolescents.

Antiandrogen therapies are beneficial for treating skin and hair conditions related to androgen levels.

Testosterone therapy seems safe for short-term use in postmenopausal women with low sexual desire, but more research on long-term effects is needed.

Taking spironolactone and linestrenol for androgen excess can lead to lower bone density in young women.

Hormonal therapy is effective for treating acne in adult women, especially with signs of high androgen levels.

The treatment effectively reduced hair growth and was safe for patients with PCOS, but it needs better bleeding control.

Birth control pills are effective for treating women with too much male hormone.

Doctors recommend postoperative radiation for male breast cancer, advise against testosterone for vasomotor symptoms post-adrenalectomy, suggest non-hormonal treatments for atrophic vaginitis after mastectomy, note no specific treatment for anticoagulant-induced hair loss, and call for more research on silicosis from silicon carbide exposure.

Hormonal therapies, like flutamide and cyproterone acetate, are safe and effective for treating adult women's acne, especially those with hormone imbalance or resistant acne.

Hormonal contraceptives may reduce social behavior and sexual motivation by lowering allopregnanolone levels.

Enobosarm may effectively treat androgen receptor-positive breast cancer with fewer side effects.

Hormonal treatments effectively treat acne in females and could reduce antibiotic use.

Antiandrogen treatments combined with oral contraceptives can help manage hair growth and hair loss in women with PCOS.

Localized estrogen treatments may improve skin quality with fewer risks than systemic hormone therapy.

Hormone treatments can help with women's skin and hair disorders, but they need careful monitoring and more research.

Testosterone therapy may improve mood, well-being, and sexual function in premenopausal women, but more research is needed on its long-term safety and effectiveness.

Testosterone treatment can improve sexual function and bone density in women but may have adverse effects and requires more research on safety and guidelines.

Cyproterone acetate with ethynyl estradiol significantly improved acne and seborrhea in women, but was less effective for hair loss and excessive hair growth.

Letrozole may help prevent seizures by reducing certain hormone levels.

Certain hormones can reduce skin oil and hair growth, potentially helping treat acne and excessive hair in women.

Testosterone therapy can help improve sexual function, mood, and bone density in women with low androgen levels, but more research is needed on long-term safety.

New treatments for PCOS focus on insulin resistance and reducing testosterone levels, along with traditional hormone therapies.